BDBM602708 2-[1-[2-(5-Cyanoisoindolin-2- yl)-4-oxo-6- (trifluoromethyl)chromen-8- yl]ethylamino]benzoic acid, Isomer 2::US11649227, Example 338::US20230286960, Example 338
SMILES CC(Nc1ccccc1C(O)=O)c1cc(cc2c1oc(cc2=O)N1Cc2ccc(cc2C1)C#N)C(F)(F)F
InChI Key InChIKey=GEQCCJKUZBWPFE-UHFFFAOYSA-N
Data 4 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 602708
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R](Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6×his tagged p110<...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6×his tagged p110<...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6× his tagged p110...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R](Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6× his tagged p110...More data for this Ligand-Target Pair